Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Graham

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cell Reports|February 2, 2025
The homologous recombination factors BRCA2 and PALB2 interplay with mismatch repair pathways to maintain centromere stability and cell viabilityEmily Graham, Lucia Rampazzo, Chin Wei Brian Leung, et al.
The New England Journal of Medicine|April 23, 2025
Efficacy of Baloxavir Treatment in Preventing Transmission of InfluenzaArnold S Monto, Klaus Kuhlbusch, Corrado Bernasconi, et al.
Intensive Care Medicine|October 5, 2021
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trialIvan O Rosas, George Diaz, Robert L Gottlieb, et al.
American Heart Journal|November 28, 2024
Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) studyDongngan T Truong, Brian J Harty, Jessica Bainton, et al.
The New England Journal of Medicine|February 25, 2021
Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Norbert Bräu, Michael Waters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Eclinicalmedicine|April 27, 2022
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)Ivan O Rosas, Norbert Bräu, Michael Waters, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cell Reports|February 2, 2025
The homologous recombination factors BRCA2 and PALB2 interplay with mismatch repair pathways to maintain centromere stability and cell viabilityEmily Graham, Lucia Rampazzo, Chin Wei Brian Leung, et al.
The New England Journal of Medicine|April 23, 2025
Efficacy of Baloxavir Treatment in Preventing Transmission of InfluenzaArnold S Monto, Klaus Kuhlbusch, Corrado Bernasconi, et al.
Intensive Care Medicine|October 5, 2021
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trialIvan O Rosas, George Diaz, Robert L Gottlieb, et al.
American Heart Journal|November 28, 2024
Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) studyDongngan T Truong, Brian J Harty, Jessica Bainton, et al.
The New England Journal of Medicine|February 25, 2021
Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Norbert Bräu, Michael Waters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Eclinicalmedicine|April 27, 2022
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)Ivan O Rosas, Norbert Bräu, Michael Waters, et al.
Pageof 3